Presentation is loading. Please wait.

Presentation is loading. Please wait.

Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads

Similar presentations


Presentation on theme: "Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads"— Presentation transcript:

1 Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads
Partho P. Sengupta, MD, Donald W. Northfelt, MD, Federico Gentile, MD, Jose L. Zamorano, MD, Bijoy K. Khandheria, MD  Mayo Clinic Proceedings  Volume 83, Issue 2, Pages (February 2008) DOI: / Copyright © 2008 Mayo Foundation for Medical Education and Research Terms and Conditions

2 FIGURE Proposed algorithm for monitoring trastuzumab-induced cardiotoxicity. Serial transthoracic echocardiography (ECG) is the preferred technique for assessment of ejection fraction (EF) and diastolic function. Radionuclide ventriculography can be used for determining EF if transthoracic echocardiograms are suboptimal. LV = left ventricular. Mayo Clinic Proceedings  , DOI: ( / ) Copyright © 2008 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads"

Similar presentations


Ads by Google